Goldenwell Biotech (Goldenwell Biotech) EV-to-EBITDA : -169.05 (As of May. 21, 2024)

Goldenwell Biotech EV-to-EBITDA Chart

Goldenwell Biotech Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial									-29.63	-29.58	-29.60	-24.35	-49.13

Competitive Comparison of Goldenwell Biotech's EV-to-EBITDA

For the Packaged Foods subindustry, Goldenwell Biotech's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Goldenwell Biotech's EV-to-EBITDA Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Goldenwell Biotech's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Goldenwell Biotech's EV-to-EBITDA falls into.

Goldenwell Biotech EV-to-EBITDA Calculation

Goldenwell Biotech's EV-to-EBITDA for today is calculated as:

Goldenwell Biotech's current Enterprise Value is $19.78 Mil.
Goldenwell Biotech's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Goldenwell Biotech  (OTCPK:GWLL) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Goldenwell Biotech's PE Ratio for today is calculated as:

Goldenwell Biotech's share price for today is $0.20.
Goldenwell Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Goldenwell Biotech EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Goldenwell Biotech's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Goldenwell Biotech (Goldenwell Biotech) Business Description